VXRT

GPTKB entity

Statements (53)
Predicate Object
gptkbp:instanceOf gptkb:Company
gptkbp:aimsTo vaccine efficacy
unmet medical needs
gptkbp:clinicalTrials its vaccine candidates
gptkbp:collaborations international health organizations
gptkbp:culturalHeritage professionals
gptkbp:develops therapeutics for infectious diseases
gptkbp:engagements patient advocacy efforts
gptkbp:established 2008
gptkbp:explores new therapeutic areas
gptkbp:has_a research and development
innovation in biotechnology
therapeutic candidates.
therapeutics for other viral infections
gptkbp:has_a_focus_on vaccine development
global health challenges
emerging infectious diseases
patient-centered solutions
gptkbp:has_a_mission_to enhance patient outcomes
develop innovative therapies
gptkbp:has_expertise_in stock price volatility
gptkbp:has_partnerships_with pharmaceutical companies
various research institutions
gptkbp:hasPrograms market entry
gptkbp:headquarteredIn gptkb:New_York_City
https://www.w3.org/2000/01/rdf-schema#label VXRT
gptkbp:is_a_subject_of regulatory approvals
gptkbp:is_aimed_at reduce disease burden
gptkbp:is_committed_to public health initiatives
sustainability practices
transparency in operations
clinical excellence
gptkbp:is_displayed_on ticker symbol VXRT
gptkbp:is_involved_in clinical research
preclinical studies
vaccine distribution strategies
gptkbp:is_known_for its_COVID-19_vaccine_candidate
gptkbp:is_part_of the biotechnology sector
the global vaccine initiative
gptkbp:is_recognized_for industry analysts
its scientific research
gptkbp:isEngagedIn cutting-edge technology
gptkbp:number_of_teams experienced scientists
gptkbp:participatesIn industry conferences
gptkbp:range therapeutic candidates
gptkbp:receives positive clinical trial results
gptkbp:receives_funding_from government grants
gptkbp:research_focus vaccine technology
gptkbp:tradedOn gptkb:NASDAQ
gptkbp:utilizes proprietary technology platforms
gptkbp:vision transform healthcare
gptkbp:works_with global health equity
immunotherapy solutions